Concordance of Abundance for Mutational EGFR and Co-Mutational TP53 with Efficacy of EGFR-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer

The present study aimed to investigate the influence of the mutation abundance of the epidermal growth factor receptor (EGFR) and its co-mutation with TP53 on the therapeutic efficacy of tyrosine kinase inhibitor (TKI) treatment in patients with metastatic lung adenocarcinoma (LUAD). In total, 130 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Youping, Liu, Hong, Yu, Ningjuan, Xiang, Xueping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528559/
https://www.ncbi.nlm.nih.gov/pubmed/37754531
http://dx.doi.org/10.3390/curroncol30090616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528559/
https://www.ncbi.nlm.nih.gov/pubmed/37754531
http://dx.doi.org/10.3390/curroncol30090616

Ejemplares similares